TL;DR
The U.S. has stopped funding Gavi, the global vaccine alliance, amid disputes over vaccine policies. This move risks undermining immunization efforts in lower-income nations, potentially causing increased disease and death.
The United States is currently withholding nearly $600 million in funding from Gavi, the global vaccine alliance, amid disputes over vaccine policies and safety concerns. This action threatens to disrupt immunization efforts in low-income countries, where affordable vaccines are critical. The move comes as the U.S. seeks changes in Gavi’s vaccine strategy, raising concerns among global health experts about potential setbacks in the fight against preventable diseases.
The U.S. pledged nearly $1.6 billion to Gavi in 2024, covering about 13% of its funding through 2030. However, the State Department has not released the $600 million allocated for fiscal years 2025 and 2026, despite bipartisan calls for its release. The withholding stems from disagreements over Gavi’s use of certain vaccines, specifically those containing thimerosal and the diphtheria-tetanus-pertussis (DTP) vaccine, which U.S. officials and some critics, including Robert F. Kennedy Jr., have questioned. Kennedy has publicly accused Gavi of ignoring science and relying on vaccines he claims cause harm, though these claims lack supporting evidence. The U.S. government’s stance is also influenced by broader political and ideological disputes, with some officials demanding Gavi alter its vaccination strategy before receiving funding.
Gavi, established in 2000, is the world’s largest initiative supporting immunization in lower-income countries. It relies heavily on U.S. funding, which historically has been instrumental in expanding vaccine access. The Biden administration’s refusal to release funds threatens to undermine ongoing vaccination campaigns, risking outbreaks of preventable diseases. While the U.S. has replaced older vaccines like DTwP and thimerosal-containing formulations domestically with newer options, these are often less accessible or practical in resource-limited settings where cold storage and multiple doses are challenging. Experts warn that halting funding now could lead to increased mortality from diseases such as diphtheria, tetanus, and pertussis in vulnerable populations.
Why It Matters
This development is significant because it risks reversing decades of progress in global immunization, especially in countries with limited healthcare infrastructure. Reduced vaccine access could lead to outbreaks of deadly diseases, increased child mortality, and setbacks in global health efforts. The U.S. is a major contributor to Gavi, and its withdrawal of funds signals potential political and policy shifts that may influence international health cooperation and vaccine equity worldwide.
vaccine cold storage containers
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Background
Gavi was founded in 2000 to improve vaccine access in low-income countries, supported by contributions from governments, foundations, and organizations like the WHO. The U.S. has historically been a key funder, contributing nearly $1.6 billion in 2024. Recent political disputes, including accusations by Kennedy and others, have led to increased scrutiny of Gavi’s vaccine policies. The debate centers on the safety and efficacy of certain vaccines, with some U.S. officials demanding changes before releasing funds. This confrontation occurs amid broader tensions over vaccine strategies and international health diplomacy, with the U.S. shifting away from certain global health commitments under the current administration.
“The United States remains committed to global health efforts but expects transparency and adherence to scientific standards from Gavi.”
— A U.S. State Department spokesperson
“Disruptions in funding threaten to undo years of progress in immunization, especially in vulnerable populations.”
— Seth Berkley, former Gavi CEO
children's diphtheria tetanus pertussis vaccine
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What Remains Unclear
It is still unclear how long the U.S. will continue withholding the funds and whether negotiations will result in a resolution. The full impact on global vaccination campaigns remains uncertain, as some countries may face delays or shortages in vaccine supplies.
iHealth COVID-19, Flu A&B 3-in-1 Antigen Rapid Test, Results in 15 Minutes, FDA Authorized OTC Flu & COVID Home Test, with Non-invasive Nasal Swab, Easy to Use & No Discomfort (1 Pack, 4 Tests Total)
FDA Authorized 15-Minute Flu A&B, COVID Test Kit: Over-the-counter flu and COVID test for home use with rapid…
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What’s Next
Next steps include ongoing diplomatic discussions between the U.S. and Gavi, with some officials expressing cautious optimism about reaching an agreement. International health organizations are monitoring the situation closely, preparing contingency plans to mitigate potential disruptions. The U.S. Congress and State Department are under pressure from both sides to resolve the funding impasse, which could take weeks or months to resolve.
global immunization aid supplies
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
Why is the U.S. withholding funding from Gavi?
The U.S. is withholding funds due to disagreements over Gavi’s vaccine policies, specifically concerns about the use of certain vaccines containing thimerosal and the DTP vaccine, as well as broader political and ideological disputes.
What could be the impact of this funding halt?
The halt could disrupt immunization programs in low-income countries, leading to increased outbreaks of preventable diseases and higher child mortality rates.
Is this the first time the U.S. has threatened to cut funding?
No, similar disputes have occurred in the past, often linked to political debates over vaccine safety and policy, but this is the most significant withholding of funds in recent years.
Can Gavi continue its work without U.S. funding?
While Gavi has diversified its funding sources, losing U.S. contributions would significantly reduce its capacity to support immunization programs in the poorest countries.
Source: The Atlantic
